GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,047 Cr | ₹-1,502 Cr | ₹297 Cr | ₹942 Cr | ₹970 Cr |
What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1,047 Cr |
| Mar2025 | ₹-1,502 Cr |
| Mar2024 | ₹297 Cr |
| Mar2023 | ₹942 Cr |
| Mar2022 | ₹970 Cr |
How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,047 Cr | Positive | |
| Mar2025 | ₹-1,502 Cr | Negative | |
| Mar2024 | ₹297 Cr | -68.44 | |
| Mar2023 | ₹942 Cr | -2.92 | |
| Mar2022 | ₹970 Cr | - | |
Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,594.2 Cr | -2.3% | -6.9% | 18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.3% |
-6.9% |
18.6% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses